Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2022

Jun 22, 2022

31971_dirs_2022-06-21_108a4450-c351-4c8d-968a-c7b948388c2c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2022-04-01

Reporting Person: Lalomia Brent (Vice President QA and RA)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Rsus (restricted Stock Units) $0 2029-06-17 Common Stock (1000) Direct
Rsus (restricted Stock Units) $0 2032-03-07 Common Stock (300) Direct

Footnotes

F1: Administrative error with broker report.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.

F3: Administrative error with broker report.